Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
企業コードCBUS
会社名Cibus Inc
上場日Jul 20, 2017
最高経営責任者「CEO」Dr. Peter Ronald Beetham, Ph.D.
従業員数157
証券種類Ordinary Share
決算期末Jul 20
本社所在地6455 Nancy Ridge Drive
都市SAN DIEGO
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号92121
電話番号18584500008
ウェブサイトhttps://www.cibus.com/
企業コードCBUS
上場日Jul 20, 2017
最高経営責任者「CEO」Dr. Peter Ronald Beetham, Ph.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし